Thyrocare Technologies Dirección
Dirección controles de criterios 2/4
El CEO de Thyrocare Technologies es Rahul Guha , nombrado en May 2022, tiene una permanencia de 2.5 años. compensación anual total es ₹35.00M, compuesta por 40% salario y 60% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.1% de las acciones de la empresa, por valor de ₹52.72M. La antigüedad media del equipo directivo y de la junta directiva es de 1.9 años y 2.8 años, respectivamente.
Información clave
Rahul Guha
Chief Executive Officer (CEO)
₹35.0m
Compensación total
| Porcentaje del salario del CEO | 40.0% |
| Permanencia del CEO | 2.5yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 1.9yrs |
| Promedio de permanencia en la Junta Directiva | 2.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Statutory Profit Doesn't Reflect How Good Thyrocare Technologies' (NSE:THYROCARE) Earnings Are
Oct 31
Thyrocare Technologies Limited (NSE:THYROCARE) Looks Just Right With A 26% Price Jump
Aug 01Thyrocare Technologies Limited (NSE:THYROCARE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Jul 26A Look At The Fair Value Of Thyrocare Technologies Limited (NSE:THYROCARE)
Jun 12Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹840m |
| Jun 30 2024 | n/a | n/a | ₹776m |
| Mar 31 2024 | ₹35m | ₹14m | ₹708m |
| Dec 31 2023 | n/a | n/a | ₹655m |
| Sep 30 2023 | n/a | n/a | ₹648m |
| Jun 30 2023 | n/a | n/a | ₹599m |
| Mar 31 2023 | ₹32m | n/a | ₹645m |
Compensación vs. Mercado: La compensación total ($USD414.68K) de Rahul está en línea con el promedio de empresas de tamaño similar en el mercado Indian ($USD359.99K).
Compensación vs. Ingresos: La compensación de Rahul ha sido consistente con los resultados de la empresa en el último año.
CEO
Rahul Guha (46 yo)
2.5yrs
Permanencia
₹35,000,004
Compensación
Mr. Rahul Franklin Guha serves as President of Operations at API Holdings Limited since 2024. He is Managing Director, Chief Executive Officer and Director of Thyrocare Technologies Limited from May 04, 20...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| MD, CEO & Chairman | 2.5yrs | ₹35.00m | 0.10% ₹ 52.7m | |
| Chief Financial Officer | 1.3yrs | ₹5.55m | sin datos | |
| Chief Operating Officer | no data | ₹9.32m | 0.0030% ₹ 1.6m | |
| Company Secretary & Compliance Officer | 10.2yrs | ₹3.64m | 0.040% ₹ 20.8m | |
| Head of Strategy & Investor Relations | no data | sin datos | sin datos | |
| Chief Commercial Officer | less than a year | sin datos | sin datos | |
| Vice President | no data | ₹5.33m | 0.0020% ₹ 1.0m | |
| Strategy Manager | no data | sin datos | sin datos |
1.9yrs
Permanencia media
46yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de THYROCARE no se considera experimentado ( 1.9 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| MD, CEO & Chairman | 2.5yrs | ₹35.00m | 0.10% ₹ 52.7m | |
| Non-Executive Independent Director | 7.3yrs | ₹240.00k | sin datos | |
| Non-Executive & Non-Independent Director | 3.2yrs | sin datos | sin datos | |
| Non Executive Director | 3.2yrs | sin datos | sin datos | |
| Non Executive Director | 3.1yrs | sin datos | sin datos | |
| Independent Director | 1.3yrs | ₹220.00k | sin datos | |
| Non-Executive Independent Director | 1.3yrs | ₹40.00k | sin datos | |
| Independent Director | no data | sin datos | sin datos | |
| Independent Director | less than a year | sin datos | sin datos |
2.8yrs
Permanencia media
36yo
Promedio de edad
Junta con experiencia: La junta directiva de THYROCARE no se considera experimentada (2.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.